Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1996-02-23
1998-03-31
Azpuru, Carlos
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
5147723, A61F 202, A61K 4732
Patent
active
057335656
ABSTRACT:
The present invention relates to implantable male contraceptive devices. An ethylene vinyl acetate copolymer based implant is described for delivery of an androgen and a system including an ethylene vinyl acetate copolymer based implant as well as a second implant are described for the administration of both androgen and a sterilitant. These implants may be used to provide contraception for men, as well as, for hormone therapy, treatment of enlarged prostate and other aliments.
REFERENCES:
patent: 4957119 (1990-09-01), de Nijs
patent: 5035891 (1991-07-01), Runkel et al.
patent: 5266325 (1993-11-01), Kuzma et al.
patent: 5292515 (1994-03-01), Moro et al.
"Chemical Abstracts Search," Aug. 24, 1995, 65 pages.
"Contraception With Long-Acting Subdermal Implants," The International Committee For Contraception Research Of The Population Council, Mar. 20, 1985, 351-359.
"Clinical Trial With 3-Keto-Desogestrel Subdermal Implants," Center For Biomedical Research, The Population Council, Oct. 1991, vol. 44, No. 4, 393-408.
"Contraception With Subdermal Implants Releasing The Progestin ST-1435: A Dose-Finding Study," Jan. 1992, vol. 45, No. 1, 49-55.
"7.alpha.-Methyl-Nortestosterone (MENT): The Optimal Androgen For Male Contraception," Sundaran et al., Recent Advances in Female Reproductive Health Care, 199-205.
"Long-Term Contraception With A Single Implant Of The Progestin ST-1435," Coutinho et al., Fertility& Sterility. vol. 36, No. 6, Dec. 1981, 737-740.
"ST-1435: Development of An Implant," Odlind et al., 441-449.
Contraception, Mar. 1982, vol. 25, No. 3, 300-306.
"A Contraceptive Subdermal Implant Releasing Progestin ST-1435: Ovarian Function, Bleeding Patterns and Side Effects," Laurikka-Routti et al., Fertility & Sterility, vol. 58, No. 6, Dec. 1992, 1142-1147.
"Endometrial Effects Of Transdermal Estradiol & Progestin ST-1435 In Post Menopausal Women," Suhonen et al., Fertility &Sterility, vol. 57, No. 6, Jun. 1992, 1211-1215.
Moo-Young Alfred J.
Saleh Saleh I.
Azpuru Carlos
The Population Council, Center for Biomedical Research
LandOfFree
Male contraceptive implant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Male contraceptive implant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Male contraceptive implant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-49291